Decoding Eli Lilly's Options Activity: What's the Big Picture?
Decoding Eli Lilly's Options Activity: What's the Big Picture?
Financial giants have made a conspicuous bullish move on Eli Lilly. Our analysis of options history for Eli Lilly (NYSE:LLY) revealed 14 unusual trades.
金融巨头在Eli Lilly上做出了明显的看好策略。我们对Eli Lilly（纽交所：LLY）的期权历史进行分析，发现了14笔异常交易。
Delving into the details, we found 42% of traders were bullish, while 42% showed bearish tendencies. Out of all the trades we spotted, 6 were puts, with a value of $396,530, and 8 were calls, valued at $667,031.
进一步了解细节，我们发现42%的交易者看好，而42%的交易者看淡。我们发现的所有交易中，6个是看跌期权，价值396,530美元，8个是看涨期权，价值667,031美元。
Projected Price Targets
预计价格目标
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $550.0 to $900.0 for Eli Lilly over the recent three months.
基于交易活动，看来重要的投资者们在近三个月内力争将Eli Lilly的股价拉升至550.0美元到900.0美元的价格区间。
Insights into Volume & Open Interest
成交量和持仓量分析
Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Eli Lilly's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Eli Lilly's whale trades within a strike price range from $550.0 to $900.0 in the last 30 days.
在期权交易中，查看成交量和持仓量是一个有效的方法。这些数据可以帮助你追踪Eli Lilly期权的流动性和利率，针对给定的执行价格。下面我们可以观察到Eli Lilly所有鲸鱼交易中看涨和看跌期权成交量和持仓量的演变，分别位于550.0美元到900.0美元执行价格区间内的最近30天。
Eli Lilly Option Activity Analysis: Last 30 Days
Eli Lilly期权活动分析：最近30天
Largest Options Trades Observed:
观察到的最大期权交易：
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| LLY | PUT | TRADE | BEARISH | 06/20/25 | $140.0 | $137.25 | $140.0 | $860.00 | $140.0K | 210 | 60 |
| LLY | CALL | SWEEP | BULLISH | 08/16/24 | $36.7 | $34.0 | $36.7 | $780.00 | $128.4K | 613 | 41 |
| LLY | CALL | TRADE | BEARISH | 01/17/25 | $160.0 | $155.0 | $155.0 | $660.00 | $108.5K | 303 | 7 |
| LLY | CALL | TRADE | BULLISH | 01/17/25 | $92.0 | $92.0 | $92.0 | $780.00 | $92.0K | 3.5K | 8 |
| LLY | CALL | SWEEP | BULLISH | 08/09/24 | $18.85 | $17.05 | $18.85 | $805.00 | $87.5K | 351 | 162 |
| 标的 | 看跌/看涨 | 交易类型 | 情绪 | 到期日 | 卖盘 | 买盘 | 价格 | 执行价格 | 总交易价格 | 未平仓合约数量 | 成交量 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| LLY | 看跌 | 交易 | 看淡 | 06/20/25 | $140.0 | $137.25 | $140.0 | $860.00 | 140,000美元 | 210 | 60 |
| LLY | 看涨 | SWEEP | 看好 | 08/16/24 | 36.7 | 34.0美元 | 36.7 | $780.00 | $128.4K | 613 | 41 |
| LLY | 看涨 | 交易 | 看淡 | 01/17/25 | $160.0 | $155.0 | $155.0 | $660.00 | $108.5K | 303 | 7 |
| LLY | 看涨 | 交易 | 看好 | 01/17/25 | $92.0 | $92.0 | $92.0 | $780.00 | $92.0K | 3.5K | 8 |
| LLY | 看涨 | SWEEP | 看好 | 08/09/24 | $18.85 | $17.05 | $18.85 | 805.00美元 | $87.5K | 351 | 162 |
About Eli Lilly
关于Eli Lilly
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for diabetes; and Taltz and Olumiant for immunology.
礼来是一家专注于神经科学、心脏代谢、癌症和免疫学的制药公司。礼来的主要产品包括用于癌症的维津尼奥；马天尼罗、泽普邦、贾达信、特鲁利康、胰岛素诺和人用胰岛素用于糖尿病；以及用于免疫学的塔吉特和优泰乐。
In light of the recent options history for Eli Lilly, it's now appropriate to focus on the company itself. We aim to explore its current performance.
基于最近的期权历史，现在有必要关注这家公司本身。我们旨在探索其当前表现。
Eli Lilly's Current Market Status
Eli Lilly当前的市场状况
- With a volume of 1,266,746, the price of LLY is down -3.68% at $774.84.
- RSI indicators hint that the underlying stock may be oversold.
- Next earnings are expected to be released in 3 days.
- LLY的成交量为1,266,746，价格下跌3.68%，为774.84美元。
- RSI指标表明该基础股票可能被超卖。
- 下一个收益预计在3天内发布。
What Analysts Are Saying About Eli Lilly
分析师对Eli Lilly的看法
In the last month, 5 experts released ratings on this stock with an average target price of $959.0.
在过去一个月里，有5名专家对该股票发布了评级，平均目标价为959.0美元。
- Maintaining their stance, an analyst from Barclays continues to hold a Overweight rating for Eli Lilly, targeting a price of $1025.
- Consistent in their evaluation, an analyst from Berenberg keeps a Buy rating on Eli Lilly with a target price of $1000.
- In a cautious move, an analyst from Cantor Fitzgerald downgraded its rating to Overweight, setting a price target of $885.
- An analyst from JP Morgan persists with their Overweight rating on Eli Lilly, maintaining a target price of $1000.
- Reflecting concerns, an analyst from Cantor Fitzgerald lowers its rating to Overweight with a new price target of $885.
- 巴克莱银行的分析师继续持有Eli Lilly的股票，目标价为1025美元，维持超配评级。
- 贝恩伯格的分析师继续对Eli Lilly给出买入评级，目标价为1000美元。
- 为了谨慎起见，Cantor Fitzgerald的分析师将其评级下调为超重，设定了885美元的价格目标。
- JP摩根的分析师坚持对Eli Lilly的超配评级，维持目标价为1000美元。
- 考虑到担忧，来自康泰菲兹杰拉德的分析师将其评级下调为超配，并制定了一个新的股票价格目标为885美元。
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Eli Lilly options trades with real-time alerts from Benzinga Pro.
期权交易存在更高的风险和潜在回报。精明的交易者通过不断学习、调整策略、监控多个指标以及密切关注市场动向来管理这些风险。通过来自Benzinga Pro的实时警报，了解最新的Eli Lilly期权交易信息。